McGirt Matthew J, Blessing Robert, Nimjee Shahid M, Friedman Allan H, Alexander Michael J, Laskowitz Daniel T, Lynch John R
Department of Neurosurgery, The Johns Hopkins Hospital, Baltimore, Maryland, USA.
Neurosurgery. 2004 Jun;54(6):1369-73; discussion 1373-4. doi: 10.1227/01.neu.0000125016.37332.50.
Serum brain natriuretic peptide (BNP) is elevated after subarachnoid hemorrhage (SAH), causes diuresis and natriuresis (cerebral salt wasting), and may exacerbate delayed ischemic neurological deficits. We examined the temporal relationship between serum BNP elevation, hyponatremia, and the onset of delayed ischemic neurological deficits and determined whether serum BNP levels correlated with the 2-week outcome after SAH.
Serum BNP and sodium were measured prospectively every 12 hours for 14 days in 40 consecutive patients admitted with SAH. All patients remained euvolemic, underwent transcranial Doppler assessment every 48 hours, and underwent angiography at the onset of delayed neurological deficits. New-onset neurological deficits were attributed to vasospasm only in the absence of other causes and when supported by transcranial Doppler or cerebral angiography.
Sixteen patients (40%) experienced symptomatic cerebral vasospasm after SAH. A more than threefold increase in admission serum BNP was associated with the onset of hyponatremia (P < 0.05). Mean BNP levels were similar between vasospasm and nonvasospasm patients fewer than 3 days after SAH (126 +/- 39 pg/ml versus 154 +/- 40 pg/ml; P = 0.61) but were elevated in the vasospasm cohort 4 to 6 days after SAH (285 +/- 67 pg/ml versus 116 +/- 30 pg/ml; P < 0.01), 7 to 9 days after SAH (278 +/- 72 pg/ml versus 166 +/- 45 pg/ml; P < 0.01), and 9 to 12 days after SAH (297 +/- 83 pg/ml versus 106 +/- 30 pg/ml; P < 0.01). BNP level remained independently associated with vasospasm adjusting for Fisher grade and Hunt and Hess grade (odds ratio, 1.28; 95% confidence interval, 1.1-1.6). In patients in whom vasospasm developed, mean serum BNP increased 5.4-fold within 24 hours after vasospasm onset and 11.2-fold the first 3 days after vasospasm onset. Patients with increasing BNP levels from admission demonstrated no change (0 +/- 3) in Glasgow Coma Scale score 2 weeks after SAH versus a 3.0 +/- 2 (P < 0.05) improvement in Glasgow Coma Scale score in patients without increasing serum BNP levels.
Increasing serum BNP levels independently were associated with hyponatremia, significantly increased the first 24 hours after onset of delayed ischemic neurological deficits, and predicted the 2-week Glasgow Coma Scale score.
蛛网膜下腔出血(SAH)后血清脑钠肽(BNP)升高,可引起利尿和利钠(脑性盐耗综合征),并可能加重迟发性缺血性神经功能缺损。我们研究了血清BNP升高、低钠血症与迟发性缺血性神经功能缺损发作之间的时间关系,并确定血清BNP水平是否与SAH后2周的预后相关。
对40例连续收治的SAH患者前瞻性地每12小时检测一次血清BNP和钠水平,共检测14天。所有患者均保持血容量正常,每48小时进行一次经颅多普勒评估,并在迟发性神经功能缺损发作时进行血管造影。仅在无其他病因且经颅多普勒或脑血管造影支持时,新发神经功能缺损才归因于血管痉挛。
16例(40%)患者SAH后出现症状性脑血管痉挛。入院时血清BNP升高超过三倍与低钠血症的发作相关(P<0.05)。SAH后少于3天,血管痉挛患者与非血管痉挛患者的平均BNP水平相似(126±39 pg/ml对154±40 pg/ml;P=0.61),但在SAH后4至6天(285±67 pg/ml对116±30 pg/ml;P<0.01)、7至9天(278±72 pg/ml对166±45 pg/ml;P<0.01)和9至12天(297±83 pg/ml对106±30 pg/ml;P<0.01),血管痉挛组的BNP水平升高。校正Fisher分级和Hunt及Hess分级后,BNP水平仍与血管痉挛独立相关(比值比,1.28;95%置信区间,1.1 - 1.6)。在发生血管痉挛的患者中,血管痉挛发作后24小时内平均血清BNP增加5.4倍,发作后前3天增加11.2倍。入院时BNP水平升高的患者SAH后2周格拉斯哥昏迷量表评分无变化(0±3),而血清BNP水平未升高的患者格拉斯哥昏迷量表评分改善3.0±2(P<0.05)。
血清BNP水平升高与低钠血症独立相关,在迟发性缺血性神经功能缺损发作后的最初二十四小时内显著升高,并可预测2周时的格拉斯哥昏迷量表评分。